Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 8 antisense RNA 1 (TBC1D8-AS1) is a **long non-coding RNA (lncRNA)** transcribed antisense to the TBC1D8 gene and located on chromosome 2[1][5]. As a non-coding RNA, it does not encode a protein but is believed to regulate the expression of its sense partner gene, TBC1D8, possibly through antisense transcript-mediated effects[1][5]. Evidence suggests it may participate in the regulation of **Wnt signaling** by inducing secreted Wnt antagonists, thereby modulating canonical Wnt pathway activity[7]. TBC1D8-AS1 has been implicated in the pathophysiology of cancers and possibly other disease contexts, but it is not a classical drug target such as an enzyme, receptor, or transporter[5][7]. There are no known drugs that directly target TBC1D8-AS1, and it does not serve as a common predictive biomarker in current clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 8 antisense RNA 1 (TBC1D8-AS1).